The GABA Receptors [electronic resource] /edited by S. J. Enna, Hanns Möhler.
by Enna, S. J [editor.]; Möhler, Hanns [editor.]; SpringerLink (Online service).
Material type:
Item type | Current location | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|
MAIN LIBRARY | RC321-580 (Browse shelf) | Available |
Browsing MAIN LIBRARY Shelves Close shelf browser
RC261-271 Cytokines in the Genesis and Treatment of Cancer | RM214-258 Iron Deficiency and Overload | RM214-258 Nutrition and Health in Developing Countries | RC321-580 The GABA Receptors | RG499.2-991 Women’s Health in Clinical Practice | RC254-282 Principles of Molecular Oncology | RC870-923.2 Chronic Prostatitis/Chronic Pelvic Pain Syndrome |
The GABA Receptors -- Functional Relevance of GABAA-Receptor Subtypes -- Trafficking of Postsynaptic GABAA Receptors by Receptor-Associated Proteins -- Subunit Composition and Structure of GABAA-Receptor Subtypes -- Differential Activation of GABAA-Receptor Subtypes -- GABAA-Receptor Mutations Associated With Idiopathic Generalized Epilepsies and Febrile Seizures -- Abuse and Dependence Liability of GABAA-Receptor Modulators -- Mechanisms of GABAA and GABAB Receptor Gene Regulation and Cell Surface Expression -- Chemistry of GABAB Modulators -- The Unusual Functioning of the GABAB-Receptor Heterodimer -- Characteristics of GABAB Receptor Mutant Mice -- GABAB Receptor ad a Potential Therapeutic Target.
"The Gaba Receptors, Third Edition", presents a critical appraisal of our current understanding of the molecular, behavioral, biochemical, clinical, and pharmacological properties of GABA receptors. Emphasis is placed on exploring cutting-edge findings on the structural properties of receptor sites, mechanisms of receptor expression, chemical agents that differentiate receptor subtypes, and phenotypes displayed by GABA receptor null mice. Chapters in this updated and expanded edition examine such topics as GABA receptor subtypes, trafficking postsynaptic GABA receptors, GABA receptor mutations associated with idiopathic generalized epilepsies and febrile seizures, and GABA receptors as a potential therapeutic target.
There are no comments for this item.